Analogues of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds. 1991

J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
Nova Pharmaceutical Corporation, Baltimore, Maryland 21224-6522.

Oxybutynin chloride [4-(diethylamino)-2-butynyl alpha-cyclohexyl-alpha-hydroxybenzeneacetate hydrochloride, Ditropan] is widely used for the relief of symptoms in neurogenic bladder. This is a result of its combined anticholinergic, antispasmodic, and local anesthetic activities. In a study directed toward development of agents possessing the beneficial properties of oxybutynin, but having a longer duration of action, a series of metabolically more stable keto analogues of the parent ester, i.e. substituted 7-amino-1-hydroxy-5-heptyn-2-ones along with some analogues and derivatives, was prepared and evaluated for in vitro and in vivo antimuscarinic action in guinea pig preparations. Several members of the series were potent antimuscarinics having a longer duration of activity than that of oxybutynin in a guinea pig cystometrogram model. On the basis of its in vitro and in vivo antimuscarinic activity, coupled with a 5-fold greater duration of action than that of oxybutynin, 1-cyclobutyl-7-(dimethylamino)-1-hydroxy-1-phenyl-5-heptyn-2-one (14b) was selected for clinical evaluation.

UI MeSH Term Description Entries
D008333 Mandelic Acids Analogs or derivatives of mandelic acid (alpha-hydroxybenzeneacetic acid). Acids, Mandelic
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D002217 Carbachol A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS. Carbamylcholine,Carbacholine,Carbamann,Carbamoylcholine,Carbastat,Carbocholine,Carboptic,Doryl,Isopto Carbachol,Jestryl,Miostat,Carbachol, Isopto
D003503 Cyclobutanes Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes

Related Publications

J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
June 1993, Drug design and discovery,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
March 1970, Journal of medicinal chemistry,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
May 1975, Journal of medicinal chemistry,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
November 1978, Die Pharmazie,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
June 1974, Journal of pharmaceutical sciences,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
August 2017, The Journal of organic chemistry,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
March 1948, Journal of the Chemical Society,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
May 1992, Journal of medicinal chemistry,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
January 1990, Journal of medicinal chemistry,
J P Carter, and L Noronha-Blob, and V H Audia, and A C Dupont, and D W McPherson, and K J Natalie, and W J Rzeszotarski, and C J Spagnuolo, and P P Waid, and C Kaiser
March 1967, Journal of medicinal chemistry,
Copied contents to your clipboard!